The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.75
CRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting-Publication of Circular

4 Nov 2022 15:10

RNS Number : 4240F
Coral Products PLC
04 November 2022
 

4 November 2022

Coral Products plc

(the "Company", the "Group" or "Coral")

Proposed cancellation of Share Premium Account and Capital Redemption Reserve

 

Introduction

 

Coral Products PLC, a specialist in the design, manufacture and supply of injection moulded plastic products based in Wythenshawe, Manchester announces that it will today publish a shareholder circular (the "Circular") containing a notice of general meeting (the "General Meeting") for the purposes of approving the cancellation of the Company's share premium account (the "Share Premium Account") and capital redemption reserve (the "Capital Redemption Reserve"). The cancellation of the Share Premium Account and Capital Redemption Reserve together comprise the "Reduction of Capital".

Background and reasons for the Reduction of Capital

 

The Companies Act 2006 (the "Act") only permits a company to make distributions to its shareholders out of its profits available for that purpose. Such profits are broadly a company's accumulated realised profits so far as not previously utilised by distribution or capitalisation less its accumulated realised losses.

 

The Company has been advised by its legal advisors not to rely on the wording set out in the special resolution to cancel the Share Premium Account and Capital Redemption Reserve, tabled at the general meeting of the Company on 29 September 2022. The Company's solicitors have instead advised the Company to proceed on the basis of the wording of the special resolution as set out in the Circular to convene the General Meeting in order both to facilitate the Reduction of Capital and to cover the increased sum currently standing to the credit of the Company's Share Premium Account and Capital Redemption Reserve (the "Resolution").

 

As at 30 April 2022, the Company had an accumulated surplus on its profit and loss account of £4,906,000 and there was £5,621,000 standing to the credit of the Company's Share Premium account and £1,061,000 standing to the credit of the Company's Capital Redemption Reserve. In October 2022, the Company issued 4,335,055 new shares, increasing the share premium account by £650,000 to £6,272,000. During the period since 30 April 2022, the Company resold the 7,378,655 shares held in treasury, increasing the capital redemption reserve by £136,000 to £1,197,000. The Share Premium Account and Capital Redemption Reserve are non-distributable reserves and the Company is therefore unable to use the amounts standing to the credit of these accounts for the purpose of (inter alia) making distributions to shareholders. However, the Act does permit the Company (subject to the approval of shareholders and the consent of the Court) to cancel its Share Premium Account and Capital Redemption Reserve and credit the resulting sums to the Company's profit and loss account.

 

Cancellation of the Company's Share Premium Account and Capital Redemption Reserve

 

The Board is seeking the approval of shareholders for the cancellation of the entire Share Premium Account of the Company of £6,272,000. The Board is also seeking the approval of shareholders for the cancellation of the Capital Redemption Reserve of the Company of £1,197,000.

 

The Reduction of Capital will only become effective if (in the following order) (i) the Resolution is approved by Shareholders at the General Meeting, (ii) confirmation is given by the Court and (iii) the Court Order and the approved statement of capital are delivered to and registered by Companies House.

 

The Reduction of Capital will increase the current surplus on the Company's profit/and loss account and create (subject to the creation of any special reserve) further positive distributable reserves.

 

The Board reserves the right to abandon or to discontinue (in whole or in part) any application to the Court in the event that the Board considers that the terms on which the Reduction of Capital would be (or would be likely to be) confirmed by the Court would not be in the best interests of the Company and/or the shareholders as a whole. The Directors will, prior to the making of any application to the Court for the approval of the Reduction of Capital, undertake a careful review of the Company's liabilities (including contingent liabilities) and consider the Company's ability to satisfy the Court that, as at the date (if any) on which the Court Order relating to the Reduction of Capital and the statement of capital in respect of the Reduction of Capital have both been registered by the Registrar of Companies at Companies House and the Reduction of Capital therefore becomes effective, the Company's creditors will be sufficiently protected.

 

 

General Meeting

 

The Reduction of Capital requires the approval of shareholders by special resolution at a general meeting. Accordingly, the Circular contains a notice convening a General Meeting of the Company to be held at Tatra Rotalac Ltd, Southmoor Road, Wythenshawe, Manchester, M23 9DS on 30 November 2022 at 12.00 noon at which the Resolution set out in the notice of the General Meeting will be proposed.

 

The Resolution will be proposed as a special resolution requiring a majority of not less than 75 per cent. of the votes cast.

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

 

Publication of the Circular and Form of Proxy

 

4 November 2022

Latest time and date for receipt of Forms of Proxy and CREST voting instructions

 

12.00 noon on

28 November 2022

General Meeting

 

12.00 noon on

30 November 2022

Court hearing of application to confirm the Reduction of Capital

14 December 2022

Registration of Court Order and Effective Date of the Reduction of Capital

About 27 January 2023

Note:

Each of the above times and/or dates is subject to change at the absolute discretion of the Company. If any of the above times and/or dates should change, the revised times and/or dates will be announced through a Regulatory Information Service.

 

Further details of the Reduction of Capital will be set out in the Circular, a copy of which will shortly be available on the Company's website at www.coralproducts.com

 

For further information, please contact:

 

Coral Products plc

Joe Grimmond, Chairman

 

 

Tel: 07703 518 148

 

Nominated Adviser & Broker

Cenkos LLP

Stephen Keys

Charlie Combe

 

Tel: 020 7397 1966

Financial PR

Novella

Tim Robertson

Tel: 020 3151 7008

 

This announcement has been posted to: https://coralproducts.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGGZMGMKDRGZZM
Date   Source Headline
4th Jan 20194:41 pmRNSSecond Price Monitoring Extn
4th Jan 20194:35 pmRNSPrice Monitoring Extension
3rd Jan 20193:00 pmRNSDirector/PDMR Shareholding
5th Dec 20187:00 amRNSDirector/PDMR Shareholding
3rd Dec 20183:01 pmRNSDirector/PDMR Shareholding
29th Nov 20187:00 amRNSHalf-year Report
13th Nov 20187:00 amRNSFurther re: Extension of Supply Contract
31st Oct 20184:16 pmRNSDirector/PDMR Shareholding
31st Oct 20183:09 pmRNSDirector/PDMR Shareholding
31st Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSDirector/PDMR Shareholding
23rd Oct 20181:33 pmRNSResult of AGM
23rd Oct 20187:00 amRNSAGM Statement
5th Oct 20187:00 amRNSCompliance with bank lending covenants
4th Oct 20187:00 amRNSProduct Development Partnership
1st Oct 20187:00 amRNSCompliance with bank lending covenants
27th Sep 20183:41 pmRNSFinal Results & Notice of AGM
8th Aug 20187:00 amRNSFurther re: Extension of Supply Contract
1st Aug 20187:00 amRNSTrading and Operational Update
14th Jun 20187:00 amRNSExtension of Supply Contract
20th Apr 20182:07 pmRNSHolding(s) in Company
6th Apr 201812:10 pmRNSDirector Dealing
5th Apr 201812:30 pmRNSDirector dealing
5th Apr 201810:13 amRNSHolding(s) in Company
4th Apr 201810:33 amRNSHolding(s) in Company
12th Mar 201812:55 pmRNSDirector/PDMR Shareholding
16th Feb 20187:00 amRNSDirector/PDMR Shareholding
12th Feb 20182:50 pmRNSDirector/PDMR Shareholding
8th Feb 201812:09 pmRNSDirector/PDMR Shareholding
7th Feb 201811:22 amRNSDirector/PDMR Shareholding
2nd Feb 20184:48 pmRNSDirector dealing
2nd Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20182:30 pmRNSHalf-year Report
16th Jan 20182:30 pmRNSDirectorate Change
12th Jan 20182:48 pmRNSTrading Update
11th Oct 20171:04 pmRNSResult of AGM
11th Oct 201711:48 amRNSAGM Statement
14th Sep 20177:00 amRNSFinal Results
11th Sep 201711:11 amRNSBusiness and Asset Purchase
8th Jun 20177:00 amRNSTrading Statement
7th Apr 20177:00 amRNSHaydock Production Facility Update
24th Mar 20177:00 amRNSPurchase of Assets
27th Feb 20178:49 amRNSDirectorate Change
30th Jan 201712:28 pmRNSDirector Dealing
27th Jan 201712:38 pmRNSDirectors' Dealing
27th Jan 20177:00 amRNSTrading Update
8th Dec 20167:00 amRNSHalf Yearly Report
28th Sep 201612:36 pmRNSResult of AGM
28th Sep 20167:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.